Rapid Biosense LLC

Rapid Biosense LLC was paid $1.62M by Medicaid between Dec 2020 and Feb 2023, across 19 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 59% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#32 of 108

Median peer was paid$588K

This provider vs. median2.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	111	$7K
2021	16,388	$560K
2022	30,652	$1.02M
2023	1,087	$35K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	59%	15,438	12,586	$952K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	19%	15,245	12,453	$308K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	18%	15,381	12,514	$293K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	2.0%	284	277	$33K
87428		<1%	298	266	$13K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	382	344	$11K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	421	346	$3K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	59	58	$2K
80053	Comprehensive metabolic panel	<1%	317	264	$2K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	41	39	$1K
84443	Thyroid stimulating hormone (TSH)	<1%	87	84	$1K
83036	Hemoglobin; glycosylated (A1C)	<1%	118	110	$795.96

7 more codes

82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	20	$441.18
80048	Basic metabolic panel (calcium, ionized)	<1%	60	$287.00
80061	Lipid panel	<1%	17	$166.35
83735		<1%	31	$149.91
82607		<1%	14	$149.76
87086	Culture, bacterial; quantitative colony count, urine	<1%	13	$73.48
81000		<1%	12	$36.63

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCUNNINGHAM, JOHN (CEO)